Hims & Hers Health Inc (HIMS)
NYSE • Healthcare
April 21, 2026 at 16:00 UTC
About Hims & Hers Health Inc
Hims & Hers Health operates dual consumer brands — Hims and Hers — through a telehealth platform that pairs online medical consultations with prescription fulfillment, over-the-counter treatments, and personal care products. Clinical categories cover dermatology, sexual health, mental wellness, hair care, weight management, and primary care screenings, all accessible via a mobile application and website. Licensed providers evaluate patients asynchronously or through scheduled video visits, and prescriptions are dispensed by the company's affiliated pharmacy operations, which manage the entire chain from verification through packaging and shipping. Distribution extends through a direct-to-consumer channel and select retail partnerships across the United States, blending digital acquisition with physical shelf presence.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
Hims & Hers Health Inc's Technical Indicators Summary
HIMS shows a bullish technical posture driven by a clear short-to-medium moving average advantage while the 200-day averages remain above, indicating a longer-term ceiling. Trend strength is solid with ADX around 30, and momentum measures show strength—MACD is positive and CCI supports buying—although oscillators are extended. Volume-based OBV and an intraday VWAP slightly below the current price reinforce that buyers have pushed the stock higher, while ATR indicates elevated intraday range. Technical takeaway: Bullish bias with strong short/medium momentum but stretched oscillators warrant caution.
| Indicator | Value |
|---|---|
RSI (14) | 71.25 |
Stochastic %K (14, 3, 3) | 90.38 |
CCI (20) | 176.76 |
WPR (14) | -13.86 |
Momentum (10) | 10.54 |
MFI | 78.75 |
MACD Level (12, 26) | 1.97 |
Bollinger Bands | $14.40 - $29.90 |
ATR (14) | $2.17 (7.22%) |
ADX (14) | 30.59 |
OBV | 109,005,777 |
VWAP | $29.52 |
Classic Pivot Point | $30.42 |
Fibonacci Pivot Point | $30.42 |
Simple Moving Averages | $20.22 - $38.20(5 indicators) |
Exponential Moving Averages | $23.29 - $35.63(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
Early pre-market indications show HIMS ticking up by a fraction, with a tiny 1.58% gap to an expected open near 30.23. HIMS extended its decline during the last session, ending at 29.76 after a -4.03% pullback. HIMS ticks up in pre-market as Amazon's GLP-1 program with One Medical draws healthcare-tech interest.
Price Change
from $29.76 close
$0
Trading Volume
Above avg 40.8M
58.6M
vs S&P 500 Today
Underperforming Market
-0.62%
52-Week Position
Lower range
28.3%
Updated: April 22, 2026 at 12:10 UTC
Quote Summary
HIMS Headlines
Hims & Hers Plunges on Wegovy Copycat Fallout
February 9, 2026
Hims–Novo Nordisk clash over new weight-loss pill
February 7, 2026
Hims jolts weight‑loss drug market with $49 Wegovy pill
February 5, 2026